Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCG immunotherapy--from pathophysiology to clinical practice.

Moshe Tishler1, Yehuda Shoenfeld

  • 1Department of Medicine B, Assaf Harofe Medical Center, P.O. Beer Yaacov, Zerifin, 70300, Israel.

Expert Opinion on Drug Safety
|March 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Study of the Efficacy and Safety of Subcutaneous Injections of Tocilizumab in Adults with Rheumatoid Arthritis.

The Israel Medical Association journal : IMAJ·2020
Same author

The impact of tocilizumab on anxiety and depression in patients with rheumatoid arthritis.

European journal of clinical investigation·2020
Same author

Clinical relevance of bilateral pleural effusion in patients with acute pulmonary embolism.

Internal medicine journal·2019
Same author

All-cause hospitalizations in systemic lupus erythematosus from a single medical center in Israel.

Rheumatology international·2018
Same author

Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid Arthritis.

The Israel Medical Association journal : IMAJ·2018
Same author

Prognostic significance of a prolonged international normalized ratio in elderly patients in an internal medicine ward.

Archives of gerontology and geriatrics·2017

Bacillus Calmette-Guérin (BCG) vaccine immunotherapy is a safe treatment for superficial bladder cancer. Rarely, arthritis can occur but typically responds well to nonsteroidal anti-inflammatory drugs (NSAIDs).

Area of Science:

  • Immunology
  • Oncology
  • Rheumatology

Background:

  • Intravesical Bacillus Calmette-Guérin (BCG) vaccine is a primary treatment for superficial bladder cancer.
  • While generally safe, BCG therapy can rarely cause secondary arthritis.
  • Understanding this complication is crucial for patient management.

Purpose of the Study:

  • To discuss the mechanisms behind BCG-induced arthritis.
  • To review clinical data related to this rare side effect.
  • To provide insights into managing BCG-associated arthritis.

Main Methods:

  • Literature review of reported cases of arthritis following BCG therapy.
  • Analysis of proposed pathophysiological mechanisms.
  • Discussion of clinical presentation and treatment outcomes.

Related Experiment Videos

Main Results:

  • Arthritis is an infrequent complication of intravesical BCG treatment.
  • Most cases of BCG-induced arthritis respond favorably to NSAID therapy.
  • The underlying mechanisms are not fully elucidated but involve inflammatory responses.

Conclusions:

  • BCG immunotherapy is effective for superficial bladder cancer with a favorable safety profile.
  • Arthritis is a rare but manageable adverse event associated with BCG therapy.
  • Prompt recognition and NSAID treatment are key for resolving BCG-induced arthritis.